Plasma SARS-CoV-2 RNA levels as a biomarker of lower respiratory tract SARS-CoV-2 infection in critically ill patients with COVID-19

Plasma SARS-CoV-2 viral RNA (vRNA) levels are predictive of COVID-19 outcomes in hospitalized patients, but whether plasma vRNA reflects lower respiratory tract (LRT) vRNA levels is unclear. We compared plasma and LRT vRNA levels in simultaneously collected longitudinal samples from mechanically-ven...

Full description

Saved in:
Bibliographic Details
Published inmedRxiv : the preprint server for health sciences
Main Authors Jacobs, Jana L, Naqvi, Asma, Shah, Faraaz A, Boltz, Valerie F, Kearney, Mary F, McVerry, Bryan J, Ray, Prabir, Schaefer, Caitlin, Fitzpatrick, Meghan, Methé, Barbara, Lee, Janet, Morris, Alison, Mellors, John W, Kitsios, Georgios D, Bain, William
Format Journal Article
LanguageEnglish
Published United States 11.01.2022
Online AccessGet more information

Cover

More Information
Summary:Plasma SARS-CoV-2 viral RNA (vRNA) levels are predictive of COVID-19 outcomes in hospitalized patients, but whether plasma vRNA reflects lower respiratory tract (LRT) vRNA levels is unclear. We compared plasma and LRT vRNA levels in simultaneously collected longitudinal samples from mechanically-ventilated patients with COVID-19. LRT and plasma vRNA levels were strongly correlated at first sampling (r=0.83, p<10 ) and then declined in parallel except in non-survivors who exhibited delayed vRNA clearance in LRT samples. Plasma vRNA measurement may offer a practical surrogate of LRT vRNA burden in critically ill patients, especially early in severe disease.
DOI:10.1101/2022.01.10.22269018